2-hydroxytrimipramine: metabolite of trimipramine; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 160610 |
| MeSH ID | M0192291 |
| Synonym |
|---|
| hydroxytrimipramine |
| 5-[3-(dimethylamino)-2-methylpropyl]-10,11-dihydro-5h-dibenzo[b,f]azepin-2-ol |
| 2064-15-5 |
| 2-hydroxy trimipramine |
| 11-[3-(dimethylamino)-2-methylpropyl]-5,6-dihydrobenzo[b][1]benzazepin-3-ol |
| 11-[3-(dimethylamino)-2-methyl-propyl]-5,6-dihydrobenzo[b][1]benzazepin-3-ol |
| A816780 |
| 2-hydroxytrimipramine |
| 5h-dibenz(b,f)azepin-2-ol, 5-(3-(dimethylamino)-2-methylpropyl)-10,11-dihydro- |
| FT-0670200 |
| 5-[3-(dimethylamino)-2-methylpropyl]-10,11-dihydro-5h-dibenzo[b,f]azepin-2-ol # |
| FQJSSUOYVSEYPF-UHFFFAOYSA-N |
| AKOS030241763 |
| J-013488 |
| FT-0670201 |
| DTXSID80942833 |
| 5h-dibenz[b,f]azepin-2-ol, 5-[3-(dimethylamino)-2-methylpropyl]-10,11-dihydro- |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.66) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||